Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: implications for intraoperative specimen evaluation.

Rabban JT, Mackey A, Powell CB, Crawford B, Zaloudek CJ, Chen LM.

Gynecol Oncol. 2011 Jun 1;121(3):466-71. doi: 10.1016/j.ygyno.2011.01.031. Epub 2011 Feb 24.

PMID:
21353295
[PubMed - indexed for MEDLINE]
2.

Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol.

Rabban JT, Krasik E, Chen LM, Powell CB, Crawford B, Zaloudek CJ.

Am J Surg Pathol. 2009 Dec;33(12):1878-85. doi: 10.1097/PAS.0b013e3181bc6059.

PMID:
19898224
[PubMed - indexed for MEDLINE]
3.

Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol.

Powell CB, Chen LM, McLennan J, Crawford B, Zaloudek C, Rabban JT, Moore DH, Ziegler J.

Int J Gynecol Cancer. 2011 Jul;21(5):846-51. doi: 10.1097/IGC.0b013e31821bc7e3.

PMID:
21670699
[PubMed - indexed for MEDLINE]
4.

Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.

Manchanda R, Abdelraheim A, Johnson M, Rosenthal AN, Benjamin E, Brunell C, Burnell M, Side L, Gessler S, Saridogan E, Oram D, Jacobs I, Menon U.

BJOG. 2011 Jun;118(7):814-24. doi: 10.1111/j.1471-0528.2011.02920.x. Epub 2011 Mar 10.

PMID:
21392246
[PubMed - indexed for MEDLINE]
5.

Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.

Powell CB, Kenley E, Chen LM, Crawford B, McLennan J, Zaloudek C, Komaromy M, Beattie M, Ziegler J.

J Clin Oncol. 2005 Jan 1;23(1):127-32.

PMID:
15625367
[PubMed - indexed for MEDLINE]
6.

Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations.

Rabban JT, Crawford B, Chen LM, Powell CB, Zaloudek CJ.

Am J Surg Pathol. 2009 Jan;33(1):111-9. doi: 10.1097/PAS.0b013e31817d74a7.

PMID:
18830124
[PubMed - indexed for MEDLINE]
7.

Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.

Rabban JT, Barnes M, Chen LM, Powell CB, Crawford B, Zaloudek CJ.

Am J Surg Pathol. 2009 Aug;33(8):1125-36. doi: 10.1097/PAS.0b013e31819e986a.

PMID:
19440148
[PubMed - indexed for MEDLINE]
8.

Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis.

Yates MS, Meyer LA, Deavers MT, Daniels MS, Keeler ER, Mok SC, Gershenson DM, Lu KH.

Cancer Prev Res (Phila). 2011 Mar;4(3):463-70. doi: 10.1158/1940-6207.CAPR-10-0266. Epub 2011 Jan 28.

PMID:
21278312
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.

Lamb JD, Garcia RL, Goff BA, Paley PJ, Swisher EM.

Am J Obstet Gynecol. 2006 Jun;194(6):1702-9.

PMID:
16731090
[PubMed - indexed for MEDLINE]
10.

Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens.

Reitsma W, de Bock GH, Oosterwijk JC, Bart J, Hollema H, Mourits MJ.

Eur J Cancer. 2013 Jan;49(1):132-41. doi: 10.1016/j.ejca.2012.07.021. Epub 2012 Aug 21.

PMID:
22921157
[PubMed - indexed for MEDLINE]
11.

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.

Finch A, Shaw P, Rosen B, Murphy J, Narod SA, Colgan TJ.

Gynecol Oncol. 2006 Jan;100(1):58-64. Epub 2005 Aug 31.

PMID:
16137750
[PubMed - indexed for MEDLINE]
12.

Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.

Rebbeck TR, Kauff ND, Domchek SM.

J Natl Cancer Inst. 2009 Jan 21;101(2):80-7. doi: 10.1093/jnci/djn442. Epub 2009 Jan 13.

PMID:
19141781
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers.

Rhiem K, Foth D, Wappenschmidt B, Gevensleben H, B├╝ttner R, Ulrich U, Schmutzler RK.

Arch Gynecol Obstet. 2011 Mar;283(3):623-7. doi: 10.1007/s00404-010-1476-3. Epub 2010 Apr 29.

PMID:
20428881
[PubMed - indexed for MEDLINE]
14.

Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2.

Kauff ND, Barakat RR.

J Clin Oncol. 2007 Jul 10;25(20):2921-7. Review.

PMID:
17617523
[PubMed - indexed for MEDLINE]
15.

Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature.

Carcangiu ML, Peissel B, Pasini B, Spatti G, Radice P, Manoukian S.

Am J Surg Pathol. 2006 Oct;30(10):1222-30.

PMID:
17001151
[PubMed - indexed for MEDLINE]
16.

Diathermy-induced injury may affect detection of occult tubal lesions at risk-reducing salpingo-oophorectomy.

Manchanda R, Silvanto A, Abdelraheim A, Burnell M, Johnson M, Saridogan E, Rosenthal AN, Brunell C, Aslam N, Vashisht A, Pandis G, Jacobs I, Menon U, Benjamin E.

Int J Gynecol Cancer. 2012 Jun;22(5):881-8. doi: 10.1097/IGC.0b013e31824b4093.

PMID:
22572844
[PubMed - indexed for MEDLINE]
17.

Occult ovarian cancer at the time of risk-reducing salpingo-oophorectomy.

Powell CB.

Gynecol Oncol. 2006 Jan;100(1):1-2. No abstract available.

PMID:
16368438
[PubMed - indexed for MEDLINE]
18.

Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status.

Colgan TJ, Murphy J, Cole DE, Narod S, Rosen B.

Am J Surg Pathol. 2001 Oct;25(10):1283-9.

PMID:
11688463
[PubMed - indexed for MEDLINE]
19.

Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis.

Paley PJ, Swisher EM, Garcia RL, Agoff SN, Greer BE, Peters KL, Goff BA.

Gynecol Oncol. 2001 Feb;80(2):176-80.

PMID:
11161856
[PubMed - indexed for MEDLINE]
20.

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B, Murphy J, Ghadirian P, Friedman E, Foulkes WD, Kim-Sing C, Wagner T, Tung N, Couch F, Stoppa-Lyonnet D, Ainsworth P, Daly M, Pasini B, Gershoni-Baruch R, Eng C, Olopade OI, McLennan J, Karlan B, Weitzel J, Sun P, Narod SA; Hereditary Ovarian Cancer Clinical Study Group.

JAMA. 2006 Jul 12;296(2):185-92.

PMID:
16835424
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk